PANAGORA ASSET MANAGEMENT INC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 883677 Boston, MA

Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$531,831

+$203,637 QoQ

Shares Held

466,519

+97.6% QoQ

Ownership

0.168%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 53 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $63,074,679 across 13 Drug Manufacturers - Specialty & Generic names. AKBA ranks #10 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	765,543	$40,114,453
2	AMRX	Amneal Pharmaceuticals, Inc.	443,647	$7,679,529
3	ELAN	Elanco Animal Health Inc	216,960	$5,339,385
4	EBS	Emergent BioSolutions Inc.	329,060	$2,757,522
5	XERS	Xeris Biopharma Holdings, Inc.	227,579	$1,802,425
6	ZTS	Zoetis Inc.	22,499	$1,616,778
7	UTHR	UNITED THERAPEUTICS Corp	2,880	$1,560,470
8	TEVA	Teva Pharmaceutical Industries Ltd	18,763	$635,690

All Filings in AKBA

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$531,831	466,519	+97.6%	Shares	Sole	2026-08-06
2026-03-31	$328,194	236,111	0.0%	Shares	Sole	2026-05-14
2025-12-31	$380,138	236,111	-0.0%	Shares	Sole	2026-02-13
2025-09-30	$644,727	236,164	+12.3%	Shares	Sole	2025-11-13
2025-06-30	$765,146	210,205	-16.2%	Shares	Sole	2025-08-13
2022-06-30	$88,565	250,894	0.0%	Shares	Sole	2022-08-15
2022-03-31	$180,141	250,894	+0.1%	Shares	Sole	2022-05-12
2021-12-31	$566,493	250,661	+0.3%	Shares	Sole	2022-02-10
2021-09-30	$719,467	249,815	+253.9%	Shares	Sole	2021-11-10
2021-06-30	$267,520	70,586	+131.5%	Shares	Sole	2021-08-11
2020-09-30	$76,522	30,487	—	Shares	Sole	2020-11-13
No filing history on record for this holder in this stock.